1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Embolotherapy Market – by Product

1.3.2        Middle East & Africa Embolotherapy Market – by Disease Indication

1.3.3        Middle East & Africa Embolotherapy Market – by Procedure

1.3.4        Middle East & Africa Embolotherapy Market – by End User

1.3.5        Middle East & Africa Embolotherapy Market– By Country

2.           Middle East & Africa Embolotherapy Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Embolotherapy Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           Middle East & Africa Embolotherapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Boosting Incidence of Cancer Cases

5.1.2        Surging Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2         Market Restraints

5.2.1        Presence of Other Alternative Therapies

5.3         Market Opportunity

5.3.1        Widening Applications of Embolotherapy

5.4         Market Trend

5.4.1        Higher Use of Liquid Embolic Agents

5.5         Impact analysis

6.           Middle East & Africa Embolotherapy Market Analysis

6.1         Middle East & Africa Embolotherapy Market Revenue Forecast and Analysis

7.           Middle East & Africa Embolotherapy Market – by Product

7.1         Overview

7.2         Middle East & Africa Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3         Embolic Agents

7.3.1        Overview

7.3.2        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3        Microspheres

7.3.3.1          Overview

7.3.3.2          Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4        Embolic Coils

7.3.4.1          Overview

7.3.4.2          Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5        Embolic Plug Systems

7.3.5.1          Overview

7.3.5.2          Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6        Detachable Balloons

7.3.6.1          Overview

7.3.6.2          Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7        Liquid Embolic Agents

7.3.7.1          Overview

7.3.7.2          Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8        Others

7.3.8.1          Overview

7.3.8.2          Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Support Devices

7.4.1        Overview

7.4.2        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3        Microcatheters

7.4.3.1          Overview

7.4.3.2          Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4        Guidewires

7.4.4.1          Overview

7.4.4.2          Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Embolotherapy Market Analysis – by Disease Indication

8.1         Overview

8.2         Middle East & Africa Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3         Cancer

8.3.1        Overview

8.3.2        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Liver Cancer

8.3.2.1.1          Overview

8.3.2.1.2          Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Kidney Cancer

8.3.2.2.1          Overview

8.3.2.2.2          Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Other Cancers

8.3.2.3.1          Overview

8.3.2.3.2          Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Peripheral Vascular Diseases

8.4.1        Overview

8.4.2        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurological Diseases

8.5.1        Overview

8.5.2        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Urological and Nephrological Disorders

8.6.1        Overview

8.6.2        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Gastrointestinal Disorders

8.7.1        Overview

8.7.2        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Embolotherapy Market Analysis – by Procedure

9.1         Overview

9.2         Middle East & Africa Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3         Transcatheter Arterial Embolization (TAE)

9.3.1        Overview

9.3.2        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1        Overview

9.4.2        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Transarterial Chemoembolization (TACE)

9.5.1        Overview

9.5.2        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Embolotherapy Market Analysis – By End User

10.1      Overview

10.2      Middle East & Africa Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Ambulatory Surgical Centers

10.4.1     Overview

10.4.2     Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Other End Users

10.5.1     Overview

10.5.2     Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.        Middle East & Africa Embolotherapy Market – Country Analysis

11.1      Overview

11.1.1     Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1       Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.3       Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.1.3.1    Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.1.3.2    Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.1.4       Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.1.4.1    Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.1.5       Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.1.6       Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.2       South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.3       South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.2.3.1    South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.2.3.2    South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.2.4       South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.2.4.1    South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.2.5       South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.2.6       South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.3       UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3       UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.3.3.1    UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.3.3.2    UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.3.4       UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.3.4.1    UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.3.5       UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.3.6       UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.4       Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3       Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.4.3.1    Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.4.3.2    Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.4.4       Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication  (US$ Million)

11.1.1.4.4.1    Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.4.5       Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.4.6       Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

12.        Middle East & Africa Embolotherapy Market –Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott Laboratories

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Boston Scientific Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Cook Medical LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Johnson & Johnson

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Medtronic

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Acandis GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Balt USA LLC

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Stryker Corporation

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Guerbet LLC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Terumo Corporation

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 2.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 3.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 4.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 5.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 6.             Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 7.             Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 8.             South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 9.             South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 10.          South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 11.          South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 12.          South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 13.          South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 14.          South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 15.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 16.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 17.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 18.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 19.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 20.          UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 21.          UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 22.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 23.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 24.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 25.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 26.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 27.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure  (US$ Million)

Table 28.          Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 29.          Organic Developments Done by Companies

Table 30.          Inorganic Developments Done by Companies

Table 31.          Glossary of Terms, Middle East & Africa Embolotherapy Market

LIST OF FIGURES

Figure 1.           Middle East & Africa Embolotherapy Market Segmentation

Figure 2.           Middle East & Africa Embolotherapy Market, By Country

Figure 3.           Middle East & Africa Embolotherapy Market Overview

Figure 4.           Embolic Agents Held Largest Share of Product Segment in Middle East & Africa Embolotherapy Market

Figure 5.           Middle East & Africa Embolotherapy Market in Saudi Arabia to Show Remarkable Growth During Forecast Period

Figure 6.           Middle East & Africa Embolotherapy Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9.           Middle East & Africa Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Middle East & Africa Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11.        Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Middle East & Africa Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22.        Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Middle East & Africa Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32.        Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Middle East & Africa Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36.        Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Middle East & Africa: Embolotherapy Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 40.        Middle East & Africa Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)

Figure 41.        Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 43.        UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)